Research - , , United States
Bio-Com International, a biotech commercial-development consultancy, provides expert advisory services for translating emerging innovative advancements from the bench to the marketplace. To build & sustain its clients' competitive advantage, Bio-Com assists with risk/reward assessment & decision making. The firm also evaluates the economic impact of proprietary technologies for all phases of the intellectual property life cycle. Programs entail:• Conduct strategic business roadmapping: tech/market gap analysis of new opps• Deploy rigorous financial analyses driving value-based negotiations & decisions• Optimize R&D / product dev. resource allocation by analyzing capital budgeting / investments as Real Options• Build winning product & corp. strategies by employing discovery-driven planning & customer development• Provide forward-thinking market info, research & business intelligence• Assess & mitigate potential patent infringement, transactional & operational risksBio-Com offers formidable financial & commercial capabilities plus technical/IP expertise. A key differentiator stems from its cross-functional BIOSCIENCE-IP-BUSINESS experience. NPV-driven quantitative tools are central to the firm's sweet spot: decision-analysis & strategy-development. Projects include evaluating the commercial potential of:• Molecular diagnostics (mDx) & next generation sequencing (NGS) platforms• Genomics-guided drug discovery & development tools• CDx-stratified targeted therapeutics aka personalized / precision medicine
WordPress.org
Gravity Forms
Google Cloud Hosting
Vimeo
Mobile Friendly